Children’s Brain Tumor Network Dataset Now Accessible on Kids First Data Resource Center Portal
PHILADELPHIA, Oct. 15, 2024 /PRNewswire/ -- The Gabriella Miller Kids First Data Resource Center (Kids First DRC) announces the addition...
Cancer
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
Collaboration to Enable Sequencing of Cellular Biopsies ZÜRICH and VIENNA, Oct. 15, 2024 /PRNewswire/ -- Cytosurge AG, a leader in...
Integra Connect Teams Up with Jaan Health and Sweeten Health to Advance Chronic Care Management for Oncology
The collaboration will enable transformational, proactive care at scale across the largest oncology provider footprint in the United States WEST...
NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024...
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of...
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
HONG KONG, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced...
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), an oncology company dedicated to enhancing outcomes for patients...
mPATH Health in the Spotlight as Part of the NCI Investor Initiatives Program
Winston-Salem based digital health company will showcase its technology at world-famous HLTH Conference WINSTON-SALEM, N.C., Oct. 14, 2024 /PRNewswire/ -- mPATH®...
Rural Hospitals Strengthen Care and Finances by Embracing Data-Driven Solutions
FARMINGTON, Utah, Oct. 14, 2024 /PRNewswire/ -- REDi Health Analytics, LLC ("REDi Health") partnered with a state health department to...
Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
NEW YORK, NY / ACCESSWIRE / October 4, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation...
21st TAITA Annual Conference Explores Taiwan’s AI Era Strategies in the Global Tech Supply Chain
TAIPEI, Oct. 13, 2024 /PRNewswire/ -- The upcoming 21st TAITA-SV Annual Conference, scheduled for Saturday, October 19, 2024, at the...
Quest PharmaTech Announces Results from AGM
EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results...
INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
Boca Raton, Florida, Oct. 11, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and...
Auron Announces Poster Presentation at 2024 PCF Annual Scientific Retreat
NEWTON, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by...
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Realigning resources to focus on clinical advancement of Selected TIL therapyReducing employee headcount by approximately 60%Streamlining operations with cash runway...
Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for...
FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival compared with...
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an...
Immatics Announces Pricing of $150 Million Public Offering
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in...